ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 14th April, 2021 on account of Dr. Baba Saheb Ambedkar Jayanti.

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2%
Thu, 11 Feb

ASTRAZENECA PHARMA has announced its results for the quarter ended December 2020. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-19*
3
Sep-20*
3
Dec-20*
QoQ ChangeYoY Change
Net SalesRs m2,2392,0952,003-4.4%-10.5%
Other incomeRs m354729-37.9%-15.4%
TurnoverRs m2,2732,1422,032-5.1%-10.6%
ExpensesRs m1,8711,7371,695-2.4%-9.4%
Gross profitRs m368358307-14.0%-16.4%
DepreciationRs m48465110.6%7.1%
InterestRs m333-6.1%-4.1%
Profit before taxRs m352356283-20.4%-19.6%
TaxRs m859272-21.5%-14.5%
Profit after taxRs m267263211-20.1%-21.2%
Gross profit margin%16.417.115.4
Effective tax rate%24.126.025.6
Net profit margin%11.712.310.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 10.5% on a year-on-year (YoY) basis. The expenses were down by 9.4% YoY during the same period.
  • The company's operating profit declined by 16.4% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 15.4% in 3QFY21 as against 16.4% in 3QFY20.
  • Depreciation charges increased by 7.1% and finance costs declined by 4.1% YoY, respectively.
  • Other income declined by 15.4% YoY during the quarter.
  • Net profit for the quarter declined by 21.2% YoY. Net profit margins during the quarter declined from 11.7% in 3QFY20 to 10.4% in 3QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 4.4% on a quarter-on-quarter (QoQ) basis. The expenses were down by 2.4% QoQ during the same period.
  • The company's operating profit declined by 14.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 15.4% in 3QFY21 as against 17.1% in 2QFY20.
  • Net profit for the quarter declined by 20.1% QoQ, while net profit margins declined from 12.3% in 2QFY20 to 10.4% in 3QFY21.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters,please visit here.

India's Revival: A Once-in-a-Generation Wealth Making Opportunity

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 2,649.1 to Rs 3,710.1, registering a Gain of Rs 1,061.1 or around 40.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,884.2 (up 0.1%). Over the last one year it has moved up from 14,334.1 to 21,884.2, a gain of 7,550 points (up 52.7%).

Overall, the S&P BSE SENSEX is up 25.8% over the year.

Current Valuations

At the current price of Rs 3,710.1, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 122.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 37.6 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Apr 13, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS